Abstract:(1) CAFs affect the progression of ESCC by promoting lymphangiogenesis. (2) CAF‐derived exosomes promote the proliferation, invasion, migration and tube formation of TLECs. (3) CAF‐derived exosomal miR‐100‐5p affects ESCC lymphangiogenesis through the IGF1R/PI3K/ AKT pathway. Background Esophageal squamous cell carcinoma (ESCC), an aggressive gastrointestinal tumor, often has high early lymphatic metastatic potential. Cancer‐associated fibroblasts (CAFs) are primary components in tumor microenvironment (TME), and the impact of CAFs and its derived exosomes on lymphangiogenesis remains elusive. Materials and Methods CAFs and the microlymphatic vessel density (MLVD) in ESCC was examined. Exosomes were extracted from primary normal fibroblast (NFs) and CAFs. Subsequently, tumor‐associated lymphatic endothelial cells (TLECs) were treated with these exosomes, and the effect on their biological behavior was examined. miR‐100‐5p was selected as the target miRNA, and its effect on TLECs was examined. The target of miR‐100‐5p was predicted and confirmed. Subsequently, IGF1R, PI3K, AKT, and p‐AKT expression in TLECs and tumors treated with exosomes and miR‐100‐5p were examined. Results A large number of CAFs and microlymphatic vessels were present in ESCC, leading to a poor prognosis. CAF‐derived exosomes promoted proliferation, migration, invasion, and tube formation in TLECs. Further, they also enhanced lymphangiogenesis in ESCC xenografts. miR‐100‐5p levels were significantly lower in CAF‐derived exosomes than in NF‐derived exosomes. miR‐100‐5p inhibited proliferation, migration, invasion, and tube formation in TLECs. Further, miR‐100‐5p inhibited lymphangiogenesis in ESCC xenografts. Mechanistic studies revealed that this inhibition was mediated by the miR‐100‐5p‐induced inhibition of IGF1R/PI3K/AKT axis. Conclusion Taken together, our study demonstrates that CAF‐derived exosomes with decreased miR‐100‐5p levels exhibit pro‐lymphangiogenesis capacity, suggesting a possibility of targeting IGF1R/PI3K/AKT axis as a strategy to inhibit lymphatic metastasis in ESCC.

Down-Regulation Of Exosomal Mir-106b-5p Derived From Cholesteatoma Perimatrix Fibroblasts Promotes Angiogenesis In Endothelial Cells By Overexpression Of Angiopoietin 2

Exosome-derived Mir-182-5p Promoted Cholangiocarcinoma Progression and Vasculogenesis by Regulating ADK/SEMA5a/PI3K Pathway

Endothelial Mir-196B-5p Regulates Angiogenesis Via the Hypoxia/mir-196B-5p/hmga2/hif1α Loop.

Tumor-Derived Exosomes Promote the Angiogenic Function of Vascular Endothelial Cells by Activating the miR-423-5p/EFNA3 Signaling Pathway

Hypoxic Pancreatic Cancer Derived Exosomal MiR-30b-5p Promotes Tumor Angiogenesis by Inhibiting GJA1 Expression

MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN/PI3K/AKT pathway

Exosomal Mir-423-5p Derived from Cerebrospinal Fluid Pulsation Stress-Stimulated Osteoblasts Improves Angiogenesis of Endothelial Cells Via DUSP8/ERK1/2 Signaling Pathway

Overexpression of HIF2α Enhances the Angiogenesis-Promoting Effect of Huc-Msc-derived Extracellular Vesicles by Stimulating Mir-146A.

Poly(norepinephrine) as a functional bio-interface for neuronal differentiation on electrospun fibers.

Abstract 17239: miRNAs Secreted by Exosomes Derived From Adipose Tissue Mesenchymal Stem Cells Overexpressing GATA-4 Increase Endothelial Cell Survival and Promote Angiogenesis

RETRACTED: Pancreatic Cancer Cells-Derived Exosomal Long Non-Coding RNA CCAT1/ Microrna-138-5p/hmga1 Axis Promotes Tumor Angiogenesis

OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway

Exosomal-miR-522-3p derived from cancer-associated fibroblasts accelerates tumor metastasis and angiogenesis via repression bone morphogenetic protein 5 in colorectal cancer

Hepatocellular carcinoma cells-derived exosomal microRNA-378b enhances hepatocellular carcinoma angiogenesis

Exosomal miR-3682-3p Suppresses Angiogenesis by Targeting ANGPT1 via the RAS-MEK1/2-ERK1/2 Pathway in Hepatocellular Carcinoma

Downregulation of miR‐100‐5p in cancer‐associated fibroblast‐derived exosomes facilitates lymphangiogenesis in esophageal squamous cell carcinoma

Manipulating bioactivities of endothelial progenitor cell-derived exosomes for promoting angiogenesis in ischemic vascular diseases

Exosomes Derived from Hypoxia-Treated Human Adipose Mesenchymal Stem Cells Enhance Angiogenesis Through the PKA Signaling Pathway

Exosomal miR-3174 induced by hypoxia promotes angiogenesis and metastasis of hepatocellular carcinoma by inhibiting HIPK3

Retinal pigment epithelial cells secrete miR-202-5p-containing exosomes to protect against proliferative diabetic retinopathy

Exosomes from microRNA‐126 overexpressing mesenchymal stem cells promote angiogenesis by targeting the PIK3R2‐mediated PI3K/Akt signalling pathway